EMPAGLIFLOZIN / LINAGLIPTIN (GLYXAMBI)
This drug is missing the following documents, can you help us by contributing something?
- On this page:
- Oppositions
Oppositions
Information related to relevant oppositions from around the world.
Patent Oppositions
The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.
Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.
| Country | Date | Who Filed | Opposition type | Opposition status | Patent type | Related patent application | More info |
|---|---|---|---|---|---|---|---|
| India | 10-02-2017 | Sankar Rajakumar | Pre-Grant | Granted | Dosages | 6148/DELNP/2011 | View/Comment |
| India | 08-04-2019 | Vee Excel Drugs & Pharmaceuticals | Pre-Grant | Granted | Dosages | 6148/DELNP/2011 | View/Comment |
Is something missing? Help us by contributing missing data: Contribute
Patent Office Decisions
This table showcases the final ruling of patent offices over cases where patents have been opposed.
To better identify the case, the number of the patent application is provided in the table below.
| Decision type | Country | Date | Patent office | Related patent application | More info |
|---|---|---|---|---|---|
| Rejection | India | 14-03-2024 | Indian Patent Office | 6148/DELNP/2011 | View/Comment |
Is something missing? Help us by contributing missing data: Contribute